Contract SPE2D322F6345
Alvogen, Inc. · Department Of Defense · January 18, 2022
Alvogen, Inc. was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on January 18, 2022 for $905 of work in medicinal and botanical manufacturing. Performance is in Morristown, NJ. This is a task or delivery order issued under parent IDIQ SPE2D017D0008. It uses firm fixed-price contract pricing.
Contract details
- PIID
- SPE2D322F6345
- Parent IDIQ
- SPE2D017D0008
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Morristown, NJ
- First action
- January 18, 2022
Description
4555995406!CLINDAMYCIN 150 MG/ML INJECTION SOLUTION
Modification timeline
-
January 18, 2022Base award$905
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $232 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $13.1K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $1.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $220.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $135 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $39.8K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2D322F6345?
Contract SPE2D322F6345 is a federal contract awarded to Alvogen, Inc. by Department Of Defense on January 18, 2022 for $905 of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 0 times since the base award.
Who won contract SPE2D322F6345?
Alvogen, Inc. won contract SPE2D322F6345 from Department Of Defense.
How much is contract SPE2D322F6345 worth?
Contract SPE2D322F6345 has obligated $905 to date.